Lever Bio's goal is to develop novel immunomodulatory antibody-based therapeutics to overcome resistance to current immunotherapies, paving the way for next-generation immunotherapies and innovative combination treatments.
Lever Bio's compounds target components of the solid tumor microenvironment to foster anti-cancer immune response enhancing recruitment, activation and sustained function of cytotoxic T lymphocytes against solid tumors.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Via Ettore De Sonnaz, 19, Turin,piedmont 10121,italy
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.leverbio.com/
- HQ
- Turin, Piedmont
Lever Bio Questions
Lever Bio's website is https://www.leverbio.com/
Lever Bio's LinkedIn profile is https://it.linkedin.com/company/lever-bio
Lever Bio has
2 employees.
View email and phone details for 2
employees at Lever Bio.
Lever Bio's industry is
Biotechnology Research
Lever Bio's top competitors are
Arsenale Bioyards,
Qomodo,
Lionhealth Società Benefit (Sb),
Identifai Labs,
Fleequid,
Wetacoo,
Cyber Guru,
Claris Ventures,
Vib,
Tac.
Lever Bio's categories are Biotechnology Research
Lever Bio's founding year is 2024
